The characteristic neuropathological feature of Alzheimer's disease (AD) is the presence of numerous senile plaques consisting of amyloid fibrils surrounded by cells and their processes (Wisniewski and Terry, 1973; Miiller-Hill and Beyreuther, 1989; Selkoe, 1989) . The principal component of these amyloid fibrils is p-amyloid protein (A/?) (Glenner and Wong, 1984; Masters et al., 1985) , an -4 kDa peptide derived from larger amyloid precursor protein (APP) encoded by transcripts derived by alternative splicing of APP pre-mRNA Kang et al., 1987; Kitaguchi et al., 1988; Ponte et al., 1988; Tanzi et al., 1988; Golde et al., 1990) . APPs are integral membrane glycoproteins of 695, 7 14,75 1, and 770 amino acids with APP-751 and -770 containing regions structurally and functionally homologous to Kunitz protease inhibitors (KPI) Van Nostrand et al., 1989) .
Studies in cultured cells reveal that APP isoforms mature through the constitutive secretory pathway and are posttranslationally modified by the addition of N-and O-linked carbohydrates and by phosphorylation and tyrosine sulfation Weidemann et al., 1989) . Some full-length precursor appears on the plasma membrane (Weidemann et al., 1989; Haass et al., 1992a,b; Sisodia, 1992) , and a fraction of cell surface-bound APP is cleaved (Haass et al., 1992a; Sisodia, 1992) within the AP sequence (Esch et al., 1990; Sisodia et al., 1990; Anderson et al., 1991; Wang et al., 1991) , an event that releases C-terminally truncated APP derivatives into the conditioned medium. The presence of secreted APP derivatives in cerebrospinal fluid indicates that this pathway is utilized in vivo (Palmert et al., 1989; Weidemann et al., 1989 ). In addition, biochemical studies demonstrate that a fraction of membranebound APP is internalized and subsequently degraded in endosomal/lysosomal compartments (Cole et al., 1989; Golde et al., 1992; Haass et al., 1992a) . Finally, in cultured cells, APPs are associated with processing events that generate and release subfragments that contain the entire Afl region (Haass et al., 1992a,b; Shoji et al., 1992) .
APP isoforms are present in the PNS and CNS (Bahmanyar et al., 1987; Palmert et al., 1988; Johnson et al., 1990; Koo et al., 1990a,b) , but neither the normal functions and processing of neural APP nor the cellular source(s) and mechanisms by which APP isoforms are processed to form AD deposits in the brain parenchyma are well understood. It has been suggested that neuronal APPs are one source of A@ deposits in the brains of aged primates (Wisniewski and Terry, 1973; Struble et al., 1985; Selkoe et al., 1987; Walker et al., 1987; Cork et al., 1990; Martin et al., 199 l) , cases of Down's syndrome (Mann and Esiri, 1989; Rumble et al., 1989; Mann et al., 1992) , and individuals with AD (Wisniewski and Terry, 1973; Cras et al., 1990; Probst et al., 199 1; Kawai et al., 1992) . Consistent with this idea are three findings: APPs are carried by rapid anterograde axonal transport (Koo et al., 1990a) ; APPs accumulate in neurites surrounding AB plaques (Cork et al., 1990; Cras et al., 199 1; Martin et al., 1991; Probst et al., 1991; Kawai et al., 1992; Mann et al., 1992) ; and there are anatomical relationships, particularly in terminal fields of the perforant pathway, between neurites and AP deposits in cases of AD (Hyman et al., 1988 (Hyman et al., , 1990 Cras et al., 1990; Probst et al., 199 1; Kawai et al., 1992) . To understand the mechanisms by which neuronal APPs participate in amyloidogenesis, it is essential to define the nature and characteristics of normally transported APP. As an initial step in these investigations, we document that APP-695 is the predominant isoform synthesized in lumbar sensory neurons and that APPs are transported anterogradely as a full-length species. Similar approaches can be used to examine the transport and processing in the normal CNS and in the CNS of animals that exhibit amyloid deposits (Struble et al., 1985; Selkoe et al., 1987; Cork et al., 1990; Martin et al., 1991 (Shivers et al., 1988) . 130 is a 30-mer oligonucleotide complementary to bases 904-933 of APP-770.
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis.
Sense and antisense oligonucleotides used in this analysis are described above. Total RNA was purified from L4 and L5 dorsal root ganglia (DRG) following homogenization of tissue in guanidinium thiocyanate and centrifugation of the lysate through a CsCl cushion (Chirgwin et al., 1979) . For reverse transcription (RT), 2 pg of total RNA and 50 pmol of antisense primer (AS1219) were heated to 65°C cooled, and then incubated with Moloney leukemia virus reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD) and deoxynucleotide triphosphates at 42°C. The reaction was terminated by heating to 95°C and diluting with 1 x PCR buffer [50 mM KCl, 10 mM Tris HCl (pH 8.3) 1.5 mM MgCl,, 0.01% gelatin]. The resulting mixture was divided into six aliquots; each aliquot was incubated in a PCR with 25 pmol of sense primer (S640), 4 pmol of '*P-5' end-labeled S640 primer, and 20 pmol of antisense primer (AS 12 19) in the presence of Taq DNA polymerase (Perkin Elmer-Cetus, Emeryville, CA). The sense primer was end labeled using T4 polynucleotide kinase and +P-adenosine triphosphate (ATP). Individual reactions were removed at either 18, 20, 2 1, 22, or 23 cycles, and one-quarter of each reaction was fractionated subsequently by electrophoresis on 2% agarose gels. Gels were first stained with ethidium bromide (EtBr) and photographed, and radioactive products were visualized following exposure of the dried gel to x-ray film. Autoradiography (ARG) was performed at room temperature without intensifying screens. The intensity of resultant signals was quantified densitometrically, using a computerized image analysis system (Loats Associates, Inc., Westminster, MD), and the logarithm of the integrated optical densities was plotted as a function of cycle number. Equations of the linear regression lines were obtained using a leastsquares regression program (Macintosh, CRICKET GRAPH).
In situ hybridization. Cryostat sections (10 pm) were cut from lumbar DRG that had previously been frozen in a dry ice/ethanol bath. 530 and 130 synthetic oligonucleotides were 3' end labeled with c+S-ATP using terminal deoxynucleotidyl transferase to specific activities of -2.5 x 10' cpm/pm. Hybridization was performed in 50% formamide and 4 x SSPE (1 x SSPE = 0.7 M NaCl, 40 mM NaH,PO,, 4 mM EDTA, pH 7.4) at 37°C using 1 pm/ml of labeled-probe per section (Koo et al., 1990) . Slides were rinsed at a final stringency of 1 x SSC at 40°C dipped in Kodak NTB-2 nuclear track emulsion, and then stained with cresyl violet. In situ images were analyzed using a computerized image analysis system (Loats Associates, Inc.) that quantifies silver grains as a function of cell cross-sectional area to generate grain density values.
Labeling/immunoprecipitation of explants and transfected cells. The L4 and L5 DRG, as well as a 2 cm segment of the sciatic nerve, were dissected from an adult rat (-250 gm) killed with 4% chloral hydrate. In parallel, we placed a ligature in the sciatic nerve of a second animal -3-4 cm distal to the L4/L5 DRG. After 10 d, we dissected a 2 cm segment of the degenerating nerve distal to the ligature. Tissues were washed in Dulbecco's Modified Eagle Medium lacking methionine (DMEM-methionine), placed into -250 ~1 of "labeling medium" consisting of DMEM-methionine, 1% dialyzed fetal calf serum, and -200 &i of 35S-methionine (> 1000 Ci/mmol), and incubated at 37°C for 2 hr. Tissues were then washed with phosphate-buffered saline (PBS) and homogenized in immunoprecipitation buffer containing detergents and protease inhibitors [ 1 x immunoprecipitation buffer (150 mM NaCl, 50 mM Tris HCl (pH 7.5) 5 mM EDTA, 0.5% NP40,0.5% Na deoxycholate) containing 50 &ml pepstatin 50 &ml leupeptin, 10 pg/ml aprotinin, 0.25 mM phenylmethylsulfonyl fluoride]. Sodium docedyl sulfate (SDS) was added to 0.25%, and samples were subsequently boiled for 5 min and centrifuged at 15,000 x g for 5 min. The pellet fraction was discarded, and APP-related molecules were immunoprecipitated from the soluble fraction with a polyclonal antibody CT1 5 raised against a synthetic peptide corresponding to the terminal 15 residues of APP, as previously described (Sisodia et al., 1990) . Radioactive (15S-methionine) protein extracted into the soluble fraction was assayed by trichloroacetic acid (TCA) precipitation, as described (Gay et al., 1989) . For immunoprecipitation of APP from DRG, nerve, and ligated-nerve extracts, we assayed 1.9 x 106, 1.11 x 1 06, and 1.76 x lo6 cpm of TCA-insoluble protein, respectively.
For the labeling of transfected cells, Chinese hamster ovary (CHO) cells stably transfected with complementary dioxyribonucleic acid(s) (cDNA) encoding human APP-695 or -770 were plated into miniwells and incubated at 37°C for 2.5 hr in "labeling medium" containing 50 PCi of YS-methionine. APP-related molecules were immunoprecipitated from detergent-solubilized cell extracts, as described above. Immunoprecipitates obtained from tissue or cell extracts were fractionated by SDS-PAGE (polyacrylamide gel electrophoresis) and visualized following fluorographic enhancement and exposure of the gel to x-ray film (Sisodia et al., 1990) .
Pulse labeling of lumbar DRG and immunoprecipitation. To pulse label proteins undergoing rapid axonal transport in lumbar sensory neurons, an adult rat was anesthetized with chloral hydrate, the left L4 and L5 DRG were exposed by laminectomy, and each DRG was injected with 2 ~1 of YS-methionine (250 pCi/pl) over a period of 10 min using a glass micropipette. Animals were killed with an overdose ofanesthesia 4 hr after injection. The DRG and a 4-cm-long segment of sciatic nerve were removed, and detergent-soluble extracts were prepared as described above. APP-related molecules from the detergent-soluble fraction of each homogenate were immunoprecipitated with polyclonal antibody CT15, described above, and RGP-3 raised against a synthetic peptide corresponding to APP residues 45-62.
Results
Lumbar sensory neurons express mRNA encoding APP isoforms that lack KPI sequences To assess the relative levels of transcripts encoding and -751/770 in the DRG, we analyzed RNA prepared from L4 and L5 DRG by RT-PCR using an "antisense" primer complementary to APP sequences C-terminal to the KPI domain (Fig. 1A) . Our preliminary studies established that the efficiency ofcDNA synthesis directed by synthetic mRNA templates, which contained or lacked KPI-encoding sequences, was identical (S. S. Sisodia, unpublished observations), a result consistent with studies by Golde et al. (1990) that utilized a similar methodology to assess APP transcript levels in the brains of controls and individuals with AD. Products of the RT reaction were incubated in a PCR with a 32P-labeled "sense" primer encoding sequences N-terminal to the KPI domain (Fig. 1A) . Under these conditions, the PCR gives rise to three specific products of 350, 5 18, and 575 base pairs (bp) that represent mRNA encoding APP-695, -75 1, and -770, respectively. PCR products were fractionated by electrophoresis and stained with EtBr (Fig. lB, left) .
Although an -350 bp product is visualized by EtBr staining at cycles 22-24, the 5 18 and 575 bp products are barely detectable. However, following exposure of the dried gel to x-ray film, the 380 bp as well as the 518 and 575 bp products are easily visualized ( Fig. 1 B, right) . Because theoretical doubling of products of PCR drops as the cycle number is increased, we chose to examine the reaction over a defined range of cycles to obtain a linear amplification of products. In addition, we utilized com- For analysis of APP mRNA in DRG, RNA was reverse transcribed using antisense primer AS 12 19 (As). Reverse-transcribed products were subseauentlv incubated in a PCR with a '*P-.5' end-labeled sense primer S640 &). B, PCR analysis of APP mRNA. Amplified products generated after 18,20,2 1,22, or 23 cycles of the PCR procedure were fractionated by agarose electrophoresis and visualized by EtBr staining (left). The gel was subsequently exposed to x-ray film to visualize labeled products (right) . PCR fragments (in bp) corresponding to amplified products were generated from transcripts encoding APP-695 (3509 bp), APP-75 l(5 18 bp), and APP-770 (575 bp). C, Quantification of PCR procedure. Computer-assisted densitometry of an ARG of the dried gel was utilized to generate data points. Data are plotted as cycle number versus log of the relative optical density. Regression lines were computed using a least- puter-assisted densitometry to analyze the ARG images obtained following exposure of dried gels to film at room temperature without the sense of intensifying screens; data are summarized as a semilog plot (Fig. 1 C) . We have intentionally omitted the data for 18 cycles on this plot because signals for the APP-751 and -770 transcripts at 18 cycles were below the sensitivity of our image analysis system. Thus, our analysis only accounts for products obtained at cycles 20-23. The equation for each line presented at the bottom of Figure 1 C was derived by a least-squares regression method. Because the regression coefficient (R*) for each line is -1, we are confident of the linearity of response for all three transcripts over the cycling range. Furthermore, the slopes of each line, particularly those that represent the APP-695 and -75 1 transcripts (0.35 and 0.41, respectively), indicate that the relative efficiency of amplification is equivalent over the cycling range. Finally, the raw data obtained by densitometry at either 22 or 23 cycles, which are within the linear range of amplification (Fig. lC, inset) , document that mRNA encoding APP-695 is expressed at -lo-fold the total level of transcripts that encode KPI-containing APP in L4/L5 DRG.
In situ hybridization In situ hybridization was used to define the cellular distribution of APP mRNA in DRG sensory neurons (Fig. 2) . Using the 530 oligonucleotide, APP-695 transcripts were detected principally in sensory neurons of the DRG ( Fig. 2A ). The grain density was similar between large and small sensory neurons, with minor labeling in non-neuronal cells. In contrast, the 130 oligonucleotide, complementary to sequences encoding the KPI insert in APP-75 l/770, showed very low labeling in DRG neurons relative to the hybridization with the J30 probe (Fig. 2B ). However, in the 130 oligonucleotide preparations, silver grains were apparent in association with non-neuronal cells, that is, fibroblasts or Schwann cells, that exhibited slightly higher average densities than those observed over sensory neurons. Because the two probes were of equal length, labeled to similar specific activities, and exposed to the emulsion for the same length of time, we are confident that the number of silver grains is indicative of the relative abundance of the respective APP mRNA species. For computer-assisted quantification of grain density, we selected a total of 111 neuronal profiles (representing 55 or 56 profiles for the KPI and APP-695 probes, respectively). Cells in each group were categorized on the basis of cross-sectional area (Fig. 2C) . The results of our in situ hybridization study of neurons strongly suggest that these cells selectively express APP-695 transcripts over KPI-encoded transcripts, irrespective of the size of the neuronal population being analyzed. The ratio of grain densities representing transcripts encoding APP-695 to KPI isoforms in small, intermediate, and large neurons was -9.7:1, -9.3:1, and -6:1, respectively. In parallel, we analyzed a population of non-neuronal cells in each section. Non-neuronal profiles were defined as those cells with cross-sectional areas of < 100 pm*. As shown in Figure 2C , the grain density analysis of non-neuronal cells ("glia") showed that APP-695 transcripts exhibited an -2.7-fold higher level of expression than KPI-encoded transcripts in these cells. Taken together with the results of PCR investigations, these studies provide strong evidence that mRNA encoding APP-695 is enriched relative to mRNA encoding KPI-containing isoforms in lumbar sensory neurons.
APP-695 is more abundant than APP-751/770 in DRG
To confirm that mRNA encoding various APP isoforms is translated efficiently in the PNS, we assessed, by in vitro labeling, the expression of APP-related polypeptides in both the DRG and the nerve. For this analysis, we compared the electrophoretie migration and glycosylation patterns of APP synthesized in the DRG or sciatic nerve to those synthesized in cultured cell lines transfected with either human APP-695 or -770 cDNA (Fig. 3) . For in vitro labeling, L4 and L5 DRG (Fig. 3, lane 1) , a 2 cm segment of sciatic nerve (lane 2) or a 2 cm segment of degenerated sciatic nerve (lane 3) was incubated in medium containing 35S-methionine. In parallel, cultured CHO cells stably transfected with human cDNA encoding APP-695 (Fig. 3,  lane 4) or APP-770 (lane 5) were labeled with 35S-methionine. After labeling, APPs were immunoprecipitated from detergentsoluble fractions with an antiserum generated against APP-695 residues 680-695 (CT 15). Immunoprecipitates were fractionated by SDS-PAGE and visualized by ARG (Fig. 3) . The specificity of this antisera for APP was verified by immunoprecipitation analysis of cultured cells transfected with APP cDNA (see below). We compared the glycosylation patterns of APP immunoprecipitated from DRG explants (Fig. 3) to previously documented patterns of APP synthesized in neuroblastoma cell lines or cells of neuroendocrine lineage (Weidemann et al., 1989 ); we assigned the -100 kDa species to immature forms of APP-695 synthesized in the endoplasmic reticulum and the -115-12.5 kDa species to APP-695 forms containing additional Golgiderived oligosaccharide modifications ( Although it appears that APP-695 is the predominant isoform synthesized in the DRG by virtue of comigration of these species with CHO cell-synthesized APP-695, we have detected some KPI-containing isoforms in DRG, as well, using an (Y-KPI antibody (data not shown).
Full-length APP-695 is transported in rat peripheral nerve
To analyze the in vivo transport of APP in sensory fibers of sciatic nerve, Yj-methionine was microinjected into the lumbar DRG, and labeled APPs were immunoprecipitated from sciatic nerve (Fig. 4) . For immunoprecipitation, we utilized an APPspecific C-terminal antiserum, described above, and an N-terminal serum, RGP-3, generated against APP residues 45-62 (Perry et al., 1988; Cras et al., 1990) . For this analysis, we assumed that the rate of fast axonal transport is between 8 and 16 mm/hr (i.e., -200-400 mm/d). Accordingly, animals were killed 4 hr following injection of ?S-methionine into the DRG. The DRG (Fig. 4, lanes 1, 3) and a segment of sciatic nerve extending 2-4 cm from the ganglia (lanes 2, 4) were isolated, and APP was immunoprecipitated from detergent-soluble extracts prepared from each tissue. An essentially indistinguishable pattern of intracellular APP forms was immunoprecipitated from ganglia with either N-or C-terminal antisera (Fig. 4, compare lanes 1,3) . The pattern of APP-related products is identical to that observed from ganglia labeled in vitro (compare Fig. 3 , lane 1, with Fig. 4, lane 3) , whereas the pattern of immunoprecipitated APP in the nerve discloses that the most abundant APP-related species likely represent the fully glycosylated (-120-125 kDa) forms of APP-695 (Fig. 4, lanes 2, 4) . Presumably, this species matures through the Golgi apparatus and is then transported anterograde in axons. Although the mature APP-695 forms of -120-125 kDa are the predominant species in axons, we also detected small amounts (-5% of all transported full-length molecules) of -140-l 50 kDa in nerve on longer ARG exposures (Fig. 4, lane 4' ). It is likely that the -140-l 50 kDa products represent the most highly glycosylated forms of APP-75 l/770. We arrived at this conclusion based on the observation that sciatic nerves labeled in vitro also gave rise to immunoprecipitable APP forms of -125 and -140-l 50 kDa (Fig. 3, lanes 2, 3) . In any event, the relative abundance of fulllength APP-695 and APP-75 l/770-related species immunoprecipitated with C-terminal antibodies from nerve closely parallels the transcript levels detected in sensory neurons by in sittl hybridization (Fig. 2) . Thus, the demonstration that fully glyco- sylated APPs synthesized in sensory neurons are present in axons and retain C-terminal epitopes (Fig. 4, lanes 4,4' ) provides unambiguous proof that APPs are transported as full-length species. Moreover, the vast majority of transported APP is fulllength protein, because comparable levels of fully glycosylated APP are recovered from the nerve using either N-or C-terminal antibodies that also immunoprecipitate similar levels of APP from ganglia (Fig. 4, compare lanes 1, 3 with lanes 2, 4) .
Although the principal isoform being transported appears to be APP-695, it is apparent that labeled APP-75 l/770 isoforms are also detected in the axon. The fact that levels of transported isoforms parallel levels of transcripts in sensory neurons provides strong evidence against selective trafficking of post-Golgi forms of APP-695 and APP-75 l/770 into the axonal compartment. It should also be noted that the N-terminal antibody also detected a minor ( < 10%) APP-related species of -95-100 kDa in the nerve (Fig. 4, lane 2 ) that is not recognized by the C-terminal antibody (compare to Fig. 4, lane 4 ). This -95-100 kDa APP-related species may represent a truncated product generated following axolemmal insertion of holo-APP. Some rapidly transported molecules are, in part, inserted into the axolemma (Griffin et al., 198 l) , and preliminary evidence suggests that, in the rabbit optic nerve, a fraction of APP synthesized by retinal ganglion neurons may be inserted into the axolemma (Morin et al., 199 1) . By analogy, we suggest that some truncated APP may be generated following insertion into the axolemma. (Koo et al., 1990a) . Following the placement of ligatures on the sciatic nerve, we compared the rates of accumulation of APP and AChE, a rapidly transported protein. The rates of accumulation of immunologically detectable APP and AChE activity at the ligature were indistinguishable, an observation consistent with the idea that APPs are carried by fast anterograde axonal transport. These initial studies could not define the transported isoforms or determine the size/structure because of local proteolysis of APP by intrinsic and extrinsic cellular responses to nerve damage at the ligature.
The present report clarifies these issues. First, PCR analysis of APP mRNA in DRG revealed that the level of mRNA encoding APP-695 was -lo-fold higher than transcripts encoding the KPI forms (Fig. 1) . Second, quantitative in situ hybridization demonstrated that mRNA encoding APP-695 is expressed between -6.l-and -9.7-fold the level of KPI-encoded mRNA in sensory neurons (Fig. 2) . This result was corroborated by the observation that the electrophoretic migration of the predominant APP species synthesized in pulsed-labeled DRG (Fig. 4) or DRG labeled as explants (Fig. 3) resembled human APP-695 synthesized in transfected CHO cells. Moreover, holo-APP-695 appears to be the principal transported isoform, but the presence of transported holo-APP-75 l/770 was clearly documented in an experiment where lumbar sensory ganglia were labeled with radioactive amino acid precursors, and APPs contained within the pulsed-labeled "wave" of rapidly transported molecules were immunoprecipitated (Fig. 4) . In either case, the preponderant fraction of radiolabeled APP recovered from normal peripheral nerves is completely mature, post-Golgi isoforms that retain the extreme C-terminus; that is, they are full length.
These studies provide compelling evidence that APP-695 is the principal isoform transported in the rat peripheral nerve. It is likely that the transmembrane glycoprotein is transported as part of membranous vesicles that are translocated, via kinesinmediated motors, along microtubules. Furthermore, our preliminary studies in several pathways of the CNS also demonstrate that APP-695 is transported in a full-length form (data not shown), and it is likely that holo-APPs are transported anterogradely to distal axons and nerve terminals. Ongoing efforts are designed to define the trafficking and processing of transported APP at terminals in the CNS. Available evidence indicates that APPs are processed both at the plasma membrane (Sisodia, 1992) and in lysosomal/endosomal compartments Haass et al., 1992a) . We speculate that alterations of the normal processing of neuronal APP at synaptic sites may generate amyloidogenic fragments that, upon additional proteolysis, form A@ deposits in the brain parenchyma of aged individuals (Struble et al.., 1985; Selkoe et al., 1987; Abraham et al., 1989; Cork et al., 1990 ) subjects with Down's syndrome (Mann and Esiri, 1989; Rumble et al., 1989; Mann et al., 1992) and patients with AD (Wisniewski and Terry, 1973; Probst et al., 199 1) .
